TrialDiabetologia2021

Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial.

David Z I Cherney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.